Literature DB >> 29611491

Defining the Role of the Environment in the Emergence and Persistence of vanA Vancomycin-Resistant Enterococcus (VRE) in an Intensive Care Unit: A Molecular Epidemiological Study.

Andie S Lee1, Elizabeth White2, Leigh G Monahan3, Slade O Jensen4, Raymond Chan1, Sebastiaan J van Hal1.   

Abstract

OBJECTIVETo describe the transmission dynamics of the emergence and persistence of vanA vancomycin-resistant enterococcus (VRE) in an intensive care unit (ICU) using whole-genome sequencing of patient and environmental isolates.DESIGNRetrospective cohort study.SETTINGICU in a tertiary referral center.PARTICIPANTSPatients admitted to the ICU over an 11-month period.METHODS VanA VRE isolated from patients (n=31) were sequenced using the Illumina MiSeq platform. Environmental samples from bed spaces, equipment, and waste rooms were collected. All vanA VRE-positive environmental samples (n=14) were also sequenced. Data were collected regarding patient ward and bed movements.RESULTSThe 31 patient vanA VRE isolates were from screening (n=19), urine (n=4), bloodstream (n=3), skin/wound (n=3), and intra-abdominal (n=2) sources. The phylogeny from sequencing data confirmed several VRE clusters, with 1 group accounting for 38 of 45 isolates (84%). Within this cluster, cross-transmission was extensive and complex across the ICU. Directionality indicated that colonized patients contaminated environmental sites. Similarly, environmental sources not only led to patient colonization but also to infection. Notably, shared equipment acted as a conduit for transmission between different ICU areas. Infected patients, however, were not linked to further VRE transmission.CONCLUSIONSGenomic sequencing confirmed a predominantly clonal outbreak of VRE with complex transmission dynamics. The environmental reservoir, particularly from shared equipment, played a key role in ongoing VRE spread. This study provides evidence to support the use of multifaceted strategies, with an emphasis on measures to reduce bacterial burden in the environment, for successful VRE control.Infect Control Hosp Epidemiol 2018;39:668-675.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29611491     DOI: 10.1017/ice.2018.29

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  6 in total

1.  The Economic Implications of Introducing Single-Patient ECG Systems for Cardiac Surgery in Australia.

Authors:  Rhodri Saunders; Amanda Hansson Hedblom
Journal:  Clinicoecon Outcomes Res       Date:  2021-08-13

Review 2.  Point-of-Care Ultrasound in the Pediatric Intensive Care Unit.

Authors:  Luke Burton; Vidit Bhargava; Michele Kong
Journal:  Front Pediatr       Date:  2022-02-01       Impact factor: 3.418

3.  Effective Treatment of Skin Wounds Co-Infected with Multidrug-Resistant Bacteria with a Novel Nanoemulsion.

Authors:  Jesse Chen; Zhengyi Cao; Jayme Cannon; Yongyi Fan; James R Baker; Su He Wang
Journal:  Microbiol Spectr       Date:  2022-04-12

4.  The Role of Whole Genome Sequencing in the Surveillance of Antimicrobial Resistant Enterococcus spp.: A Scoping Review.

Authors:  Lindsay A Rogers; Kayla Strong; Susan C Cork; Tim A McAllister; Karen Liljebjelke; Rahat Zaheer; Sylvia L Checkley
Journal:  Front Public Health       Date:  2021-06-10

5.  ATP measurement as an objective method to measure environmental contamination in 9 hospitals in the Dutch/Belgian border area.

Authors:  Andreas van Arkel; Ina Willemsen; Linda Kilsdonk-Bode; Sindy Vlamings-Wagenaars; Anne van Oudheusden; Pascal De Waegemaeker; Isabel Leroux-Roels; Martine Verelst; Evelien Maas; Anita van Oosten; Patricia Willemse; Esther van Asselen; Ella Klomp-Berens; Karen Franssen; Elise Van Cauwenberg; Jan Kluytmans
Journal:  Antimicrob Resist Infect Control       Date:  2020-05-28       Impact factor: 4.887

6.  The correlation between ATP measurement and microbial contamination of inanimate surfaces.

Authors:  Andreas van Arkel; Ina Willemsen; Jan Kluytmans
Journal:  Antimicrob Resist Infect Control       Date:  2021-08-06       Impact factor: 4.887

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.